journal article·2014-06

Methotrexate-loaded biodegradable nanoparticles: preparation, characterization and evaluation of its cytotoxic potential against U-343 MGa human neuronal glioblastoma cells

Kranti P. Musmade, Praful B. Deshpande, Prashant B. Musmade, M. Naseer Maliyakkal, A. Ranjith Kumar, M. Sreenivasa Reddy, N. Udupa

Bulletin of Materials Science· Volume 37· Issue 4
Publisher page

Abstract

Nanoparticles represent one of the attractive alternatives in the effective treatment of cancer chemotherapy. In the present work, formulation and development of a novel methotrexate (MTX)-loaded biodegradable nanoparticles using poly(D,L-lactide-co-glycolide) (PLGA) was carried out. The prepared nanoparticles were evaluated for physicochemical properties such as particle size, zeta potential, release studies, etc and also evaluated for its in vitro cytotoxic potential against U-343 MGa human neuronal glioblastoma cells. Particle size of optimized formulation was < 200 nm. There was a considerable decrease in cell viability and enhancement in cytotoxic activity of MTX-loaded nanoparticles compared to MTX alone when tested against U-343 MGa human neuronal glioblastoma cells.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications · Nanoparticles: synthesis and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (10)

Show source-provided references
1. Averineni R K, Shavi G V, Gurram A K, Deshpande P B, Arumugam K, Maliyakkal N, Reddy M S and Udupa N 2012 Bull. Mater. Sci. 35 31910.1007/s12034-012-0313-7 ↗
2. De Jong W H and Borm P J A 2008 Int. J. Nanomedicine 3 13310.2147/IJN.S596 ↗
3. Patel H V, Patel B G and Patel V A 2010 Int. J. Pharm. Res. 2 75
4. Pedeboscq S, L’Azou B, Liguoro D, Pometan J P and Cambar J 2007 Exp. Toxicol. Pathol. 58 24710.1016/j.etp.2006.08.003 ↗
5. Reddy H L, Sharma K R, Chuttani K, Mishra A K and Murthy R R 2004 The AAPS J. (Article 23)
6. Singh U V, Pandey S, Umadevi P and Udupa N 1997 Drug Del. 4 10110.3109/10717549709051880 ↗
7. Singh U V and Udupa N 1997 Acta Helvetiae 72 16510.1016/S0031-6865(97)00013-7 ↗
8. Soppimath K S, Aminabhavi T M, Kulkarni A R and Rudzinski W E 2001 J. Control Rel. 70 110.1016/S0168-3659(00)00339-4 ↗
9. Xua Z, Gu W, Huang J, Sui H, Zhou Z, Yang Y, Yan Z and Li Y 2005 Int. J. Pharm. 288 36110.1016/j.ijpharm.2004.10.009 ↗
10. Zhang Y, Jin T and Zhuo R 2005 Coll. Surf. B Biointerf. 44 10410.1016/j.colsurfb.2005.06.004 ↗